Suppr超能文献

糖尿病肾病维持性血液透析患者低血糖的发生率及影响因素:一项荟萃分析

Incidence and influencing factors for hypoglycemia in maintenance hemodialysis patients with diabetic kidney disease: a meta-analysis.

作者信息

Jiang Feifei, Wu Bin, Qin Zuolian, Xie Yongxiang, Yi Na, Chen Weifang, Xu Hang

机构信息

Nursing Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine Nanning 530023, Guangxi, China.

Dean's Office, College of Nursing, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.

出版信息

Am J Transl Res. 2024 Oct 15;16(10):5216-5227. doi: 10.62347/ESHE6987. eCollection 2024.

Abstract

The objective of this study was to evaluate the incidence of hypoglycemia in patients with diabetic kidney disease (DKD) undergoing maintenance hemodialysis (MHD) and to identify key factors influencing its occurrence. A comprehensive literature search was conducted across databases including CNKI, Wanfang data, VIP, SinoMed, PubMed, Cochrane Library, Web of Science and Embase from their inception to March 31, 2023. The search focused on studies addressing the incidence and influencing factors for hypoglycemia in DKD patients receiving hemodialysis. Eligible studies were selected based on predefined inclusion and exclusion criteria, and data were analyzed using Stata 15.0 software. A total of 24 studies involving 2388 patients were included in this meta-analysis, with 22 studies from China and 2 studies from English-speaking countries. The findings indicated that the incidence of hypoglycemia among hemodialysis patients with DKD was 41.7% (95% confidence interval (): 32.6% to 50.9%). Influencing factors associated with hypoglycemia in hemodialysis patients with DKD included age (odds ratio (OR) = 4.507, 95% : 3.272 to 6.209), course of DKD ( = 3.547, 95% : 2.523 to 4.988), use of oral hypoglycemic drugs ( = 4.643, 95% : 2.566 to 8.402), fasting plasma glucose (FPG) levels (risk ratio (RR) = 4.033, 95% : 2.594 to 6.269), insulin use ( = 8.242, 95% : 4.517 to 15.042), application of glucose-free dialysate (RR = 7.987, 95% : 4.605 to 13.855), coefficient of variation in blood glucose (CVBG) ( = 3.241, 95% : 2.071 to 5.071), mean blood glucose (MBG) ( = 2.930, 95% : 1.635 to 5.248), medication compliance ( = 4.300, 95% : 2.047 to 9.031) and self-care ability ( = 3.543, 95% : 1.766 to 7.108). Specifically, risk factors identified were age > 60 years, DKD course > 1 year, use of oral hypoglycemic drugs, FPG < 6.1 mmol/L, insulin administration before dialysis, application of glucose-free dialysate, CVBG ≥ 0.26, MBG < 8.92 mmol/L, poor medication compliance, and poor self-care ability.

摘要

本研究的目的是评估维持性血液透析(MHD)的糖尿病肾病(DKD)患者低血糖的发生率,并确定影响其发生的关键因素。从建库至2023年3月31日,在包括中国知网、万方数据、维普、中国生物医学文献数据库、PubMed、考克兰图书馆、科学引文索引和Embase在内的数据库中进行了全面的文献检索。检索重点是关于接受血液透析的DKD患者低血糖发生率及影响因素的研究。根据预先设定的纳入和排除标准选择符合条件的研究,并使用Stata 15.0软件进行数据分析。本荟萃分析共纳入24项研究,涉及2388例患者,其中22项研究来自中国,2项研究来自英语国家。研究结果表明,接受血液透析的DKD患者低血糖发生率为41.7%(95%置信区间:32.6%至50.9%)。接受血液透析的DKD患者低血糖的相关影响因素包括年龄(比值比(OR)=4.507,95%:3.272至6.209)、DKD病程(=3.547,95%:2.523至4.988)、口服降糖药的使用(=4.643,95%:2.566至8.402)、空腹血糖(FPG)水平(风险比(RR)=4.033,95%:2.594至6.269)、胰岛素的使用(=8.242,95%:4.517至15.042)、无糖透析液的应用(RR =7.987,95%:4.605至13.855)、血糖变异系数(CVBG)(=3.241,95%:2.071至5.071)、平均血糖(MBG)(=2.930,95%:1.635至5.248)、用药依从性(=4.300,95%:2.047至9.031)和自我护理能力(=3.543,95%:1.766至7.108)。具体而言,确定的危险因素为年龄>60岁、DKD病程>1年、口服降糖药使用、FPG<6.1 mmol/L、透析前胰岛素给药、无糖透析液的应用、CVBG≥0.26、MBG<8.92 mmol/L、用药依从性差和自我护理能力差。

相似文献

3
Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis.
Front Pharmacol. 2022 Nov 16;13:1015045. doi: 10.3389/fphar.2022.1015045. eCollection 2022.
6
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011.
7
Occult hypoglycemia caused by hemodialysis.
Clin Nephrol. 1999 Apr;51(4):242-7.
9
Education programmes for people with diabetic kidney disease.
Cochrane Database Syst Rev. 2011 Jun 15(6):CD007374. doi: 10.1002/14651858.CD007374.pub2.
10
The effects of glucose-free and glucose-containing dialysate during dialysis in MHD patients: a prospective cross-over study.
Perfusion. 2023 Jan;38(1):178-185. doi: 10.1177/02676591211042726. Epub 2021 Sep 19.

本文引用的文献

3
Changes in blood glucose and lactate concentrations with hemodialysis.
Artif Organs. 2022 Jan;46(1):138-145. doi: 10.1111/aor.14097. Epub 2021 Nov 1.
4
CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
Front Endocrinol (Lausanne). 2021 Sep 9;12:666008. doi: 10.3389/fendo.2021.666008. eCollection 2021.
6
Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
Diabetes Care. 2021 Jul;44(7):1647-1656. doi: 10.2337/dc21-0269. Epub 2021 May 27.
7
The consequences of hypoglycaemia.
Diabetologia. 2021 May;64(5):963-970. doi: 10.1007/s00125-020-05366-3. Epub 2021 Feb 7.
8
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report.
Kidney Int. 2020 Dec;98(6):1419-1423. doi: 10.1016/j.kint.2020.09.003.
9
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
Ann Intern Med. 2020 Aug 18;173(4):278-286. doi: 10.7326/M20-0864. Epub 2020 Jun 30.
10
Hypoglycemia in Older Patients.
Clin Geriatr Med. 2020 Aug;36(3):395-406. doi: 10.1016/j.cger.2020.04.001. Epub 2020 Apr 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验